151 related articles for article (PubMed ID: 37435869)
1. The familial risk and heritability of multiple sclerosis and its onset phenotypes: A case-control study.
Boles GS; Hillert J; Ramanujam R; Westerlind H; Olsson T; Kockum I; Manouchehrinia A
Mult Scler; 2023 Sep; 29(10):1209-1215. PubMed ID: 37435869
[TBL] [Abstract][Full Text] [Related]
2. Multiple sclerosis by phenotype in Germany.
Engelhard J; Oleske DM; Schmitting S; Wells KE; Talapala S; Barbato LM
Mult Scler Relat Disord; 2022 Jan; 57():103326. PubMed ID: 35158442
[TBL] [Abstract][Full Text] [Related]
3. Progression in familial and nonfamilial MS.
Koch M; Uyttenboogaart M; Heerings M; Heersema D; Mostert J; De Keyser J
Mult Scler; 2008 Apr; 14(3):300-6. PubMed ID: 18208881
[TBL] [Abstract][Full Text] [Related]
4. Genetic differences between primary progressive and relapsing-remitting multiple sclerosis: The impact of immune-related genes variability.
Kiselev I; Bashinskaya V; Baulina N; Kozin M; Popova E; Boyko A; Favorova O; Kulakova O
Mult Scler Relat Disord; 2019 Apr; 29():130-136. PubMed ID: 30711878
[TBL] [Abstract][Full Text] [Related]
5. Genetics of primary progressive multiple sclerosis.
Cree BA
Handb Clin Neurol; 2014; 122():211-30. PubMed ID: 24507520
[TBL] [Abstract][Full Text] [Related]
6. Serious infections in patients with relapsing and progressive forms of multiple sclerosis: A German claims data study.
Knapp R; Hardtstock F; Krieger J; Wilke T; Maywald U; Chognot C; Muros-Le Rouzic E; Craveiro L
Mult Scler Relat Disord; 2022 Dec; 68():104245. PubMed ID: 36306609
[TBL] [Abstract][Full Text] [Related]
7. Factors affecting the risk of relapsing-onset and progressive-onset multiple sclerosis.
Hedström AK; Hillert J; Olsson T; Alfredsson L
J Neurol Neurosurg Psychiatry; 2021 Oct; 92(10):1096-1102. PubMed ID: 33986119
[TBL] [Abstract][Full Text] [Related]
8. Increased socioeconomic burden in patients with primary progressive multiple sclerosis: A Danish nationwide population-based study.
Blinkenberg M; Kjellberg J; Ibsen R; Magyari M
Mult Scler Relat Disord; 2020 Nov; 46():102567. PubMed ID: 33296969
[TBL] [Abstract][Full Text] [Related]
9. Disease onset in familial and sporadic primary progressive multiple sclerosis.
Koch M; Zhao Y; Yee I; Guimond C; Kingwell E; Rieckmann P; Sadovnick D; Tremlett H;
Mult Scler; 2010 Jun; 16(6):694-700. PubMed ID: 20378663
[TBL] [Abstract][Full Text] [Related]
10. Lack of replication of KIF1B gene in an Italian primary progressive multiple sclerosis cohort.
Martinelli-Boneschi F; Esposito F; Scalabrini D; Fenoglio C; Rodegher ME; Brambilla P; Colombo B; Ghezzi A; Capra R; Collimedaglia L; Coniglio G; De Riz M; Serpente M; Cantoni C; Scarpini E; Martinelli V; Galimberti D; Comi G
Eur J Neurol; 2010 May; 17(5):740-5. PubMed ID: 20067515
[TBL] [Abstract][Full Text] [Related]
11. Global transcriptome profiling of mild relapsing-remitting versus primary progressive multiple sclerosis.
Koch MW; Ilnytskyy Y; Golubov A; Metz LM; Yong VW; Kovalchuk O
Eur J Neurol; 2018 Apr; 25(4):651-658. PubMed ID: 29316044
[TBL] [Abstract][Full Text] [Related]
12. Stressful life events and the risk of primary progressive multiple sclerosis: A population-based case-control study.
Alsharie AM; Rafiee F; Rezaeimanesh N; Moghadasi AN; Sahraian MA; Eskandarieh S
Mult Scler Relat Disord; 2021 Jun; 51():102937. PubMed ID: 33857898
[TBL] [Abstract][Full Text] [Related]
13. The cannabinoid receptor 1 gene (CNR1) and multiple sclerosis: an association study in two case-control groups from Spain.
Ramil E; Sánchez AJ; González-Pérez P; Rodríguez-Antigüedad A; Gómez-Lozano N; Ortiz P; Arroyo R; De las Heras V; Vilches C; García-Merino A
Mult Scler; 2010 Feb; 16(2):139-46. PubMed ID: 20007426
[TBL] [Abstract][Full Text] [Related]
14. Modelling the natural history of primary progressive multiple sclerosis.
Harding KE; Wardle M; Moore P; Tomassini V; Pickersgill T; Ben-Shlomo Y; Robertson NP
J Neurol Neurosurg Psychiatry; 2015 Jan; 86(1):13-9. PubMed ID: 24828900
[TBL] [Abstract][Full Text] [Related]
15. Genetic association of CASP8 polymorphisms with primary progressive multiple sclerosis.
Camiña-Tato M; Fernández M; Morcillo-Suárez C; Navarro A; Julià E; Edo MC; Montalban X; Comabella M
J Neuroimmunol; 2010 May; 222(1-2):70-5. PubMed ID: 20363033
[TBL] [Abstract][Full Text] [Related]
16. Examining the environmental risk factors of progressive-onset and relapsing-onset multiple sclerosis: recruitment challenges, potential bias, and statistical strategies.
Li Y; Saul A; Taylor B; Ponsonby AL; Simpson-Yap S; Blizzard L; Broadley S; Lechner-Scott J; ; Karabudak R; Patti F; Eichau S; Onofrj M; Ozakbas S; Horakova D; Kubala Havrdova E; Grand'Maison F; Alroughani R; Gerlach O; Amato MP; Altintas A; Girard M; Duquette P; Blanco Y; Ramo-Tello C; Laureys G; Kalincik T; Khoury SJ; Shaygannejad V; Etemadifar M; Singhal B; Mrabet S; Foschi M; Habek M; John N; Hughes S; McCombe P; Ampapa R; van der Walt A; Butzkueven H; de Gans K; McGuigan C; Oreja-Guevara C; Sa MJ; Petersen T; Al-Harbi T; Sempere AP; Van Wijmeersch B; Grigoriadis N; Prevost J; Gray O; Castillo-Triviño T; Macdonell R; Lugaresi A; Sajedi SA; ; van der Mei I
J Neurol; 2024 Jan; 271(1):472-485. PubMed ID: 37768389
[TBL] [Abstract][Full Text] [Related]
17. Progression rates and sample size estimates for PPMS based on the CLIMB study population.
Raghavan K; Healy BC; Carruthers RL; Chitnis T
Mult Scler; 2015 Feb; 21(2):180-8. PubMed ID: 25070676
[TBL] [Abstract][Full Text] [Related]
18. Influence of CCR5 delta32 polymorphism on multiple sclerosis susceptibility and disease course.
Silversides JA; Heggarty SV; McDonnell GV; Hawkins SA; Graham CA
Mult Scler; 2004 Apr; 10(2):149-52. PubMed ID: 15124759
[TBL] [Abstract][Full Text] [Related]
19. Primary Progressive Multiple Sclerosis Evolving From Radiologically Isolated Syndrome.
Kantarci OH; Lebrun C; Siva A; Keegan MB; Azevedo CJ; Inglese M; Tintoré M; Newton BD; Durand-Dubief F; Amato MP; De Stefano N; Sormani MP; Pelletier D; Okuda DT
Ann Neurol; 2016 Feb; 79(2):288-94. PubMed ID: 26599831
[TBL] [Abstract][Full Text] [Related]
20. Gene expression analysis of relapsing-remitting, primary progressive and secondary progressive multiple sclerosis.
Ratzer R; Søndergaard HB; Christensen JR; Börnsen L; Borup R; Sørensen PS; Sellebjerg F
Mult Scler; 2013 Dec; 19(14):1841-8. PubMed ID: 24085340
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
